TTFields in Unresectable MPM: STELLAR Results in Practice - ILCN.org (ILCN/WCLC)
Median Survival Time - an overview | ScienceDirect Topics
MARGENZA® Clinical Results
VYXEOS® Efficacy - Phase 3 Trial Data vs 7+3 | VYXEOS® (daunorubicin and cytarabine)
Kaplan-Meier survival analysis
Efficacy of TAGRISSO® (osimertinib) in Metastatic EGFRm NSCLC
Overall survival of patients with metastatic breast cancer in Sweden: a nationwide study | British Journal of Cancer
PADCEV® (enfortumab vedotin-ejfv) Efficacy in Patients with la/mUC
Interpreting Survival Probability in Relation to 'Number at Risk' and Median Follow-Up Times - interpret - Datamethods Discussion Forum
Biology | Free Full-Text | Influence of Performance Status on the Effectiveness of Pembrolizumab Monotherapy in First-Line for Advanced Non-Small-Cell Lung Cancer: Results in a Real-World Population
Median overall survival of the patients following all o | Open-i
Median overall survival according to changes in CA 19-9 | Open-i
Survival (time to event) data: median survival times | The BMJ
Long-term Survival with Ipilimumab: Experience from a National Expanded Access Program for Patients with Melanoma | Anticancer Research
Overall survival curve. Median overall survival time was 8.2 months.... | Download Scientific Diagram
Survival curves. (A) Overall survival (median 18.2 months). (B) PS of... | Download Scientific Diagram
Frontiers | Treatment and survival analysis for 40-year SEER data on upper esophageal cancer
Trends in glioblastoma: outcomes over time and type of intervention: a systematic evidence based analysis | SpringerLink
Overall Survival Benefit with Tebentafusp in Metastatic Uveal Melanoma | NEJM
Progression free survival rate at 9 and 18 weeks predict overall survival in patients with malignant pleural mesothelioma: An individual patient pooled analysis of 10 European Organisation for Research and Treatment of
Ambiguities in computing the median survival time. - FAQ 44 - GraphPad
Cureus | A Survival Analysis of Acute Myeloid Leukemia Patients Treated With Intensive Chemotherapy: A Single Center Experience | Article
VisualAbstract: Atezolizumab monotherapy superior to chemotherapy for treatment of non-small cell lung cancer | 2 Minute Medicine
Cancers | Free Full-Text | Identification of Predictive Factors for Overall Survival and Response during Hypomethylating Treatment in Very Elderly (≥75 Years) Acute Myeloid Leukemia Patients: A Multicenter Real-Life Experience
